Search clinical trials for: Extended Depth-of-Focus (EDOF)

Total 2146 results

University of Southern Denmark
Odense University Hospital; University of Copenhagen; Region of Southern Denmark and other collaborators

Active, not recruiting

LIFE - Lung Cancer, Immunotherapy, Frailty, Effect

Quality of Life | Venous Thromboembolism | Non-small Cell Lung Cancer | Brain Metastases

Denmark
VA Office of Research and Development

Terminated

Albuterol to Improve Respiratory Strength in SCI

Spinal Cord Injury | Respiratory Muscle Weakness

United States
Radboud University Medical Center
Sint Maartenskliniek

Active, not recruiting

Results of Extended Versus Single Dose Antibiotic Prophylaxis In Orthopedic Revision Arthroplasty in Nijmegen. (REViSION)

Surgical Site Infection | Joint Infection | Infection, Surgical Site | Infection Prosthesis Hip and Knee | Infection, Prosthesis Related | Infection Pro

Netherlands
University of Chicago
Northwestern University; National Institute on Aging (NIA)

Active, not recruiting

Behavioral Chronotype: Impact on Sleep and Metabolism

Cardiovascular Diseases | Type2 Diabetes Mellitus

United States
Epitomee medical

Completed

The Effect of Extended Use of the EPITOMEE CAPSULE (ELECT)

Overweight and Obesity

United States
San Francisco Veterans Affairs Medical Center
United States Department of Defense; Northern California Institute of Research...

Active, not recruiting

A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD

Stress Disorders, Post-Traumatic

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression

Depressive Disorder, Treatment-Resistant

United States, China
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Steady-State Study of Extended Phenytoin Sodium Capsules 100 mg and Dilantin® Kapseals® 100 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg

Healthy

United States
Istinye University

Completed

Pushing and Manual Perineal Protection Techniques

Perineal Tear | Labor Complication | Episiotomy Extended by Laceration

Turkey
Mylan Pharmaceuticals Inc

Completed

Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Alprazolam Extended-release Tablets 3 mg to Xanax XR® Tablets 3 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Applesauce Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg to Verelan® PM Extended-Release Capsules 300 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Oxybutynin Chloride Extended-Release Tablets 15 mg and Ditropan XL® Tablets 15 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Propranolol Hydrochloride Extended-Release Capsules 160 mg and Inderal® LA Capsules 160 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Oxybutynin Chloride Extended-release Tablets 10 mg and Ditropan XL® Tablets 10 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg

Healthy

United States
ViiV Healthcare
GlaxoSmithKline; Janssen Pharmaceuticals

Completed

Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants

HIV Infections

United States
Samsung Medical Center

Terminated

P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold (SMART-CHOICEII)

Coronary Artery Disease | Atherosclerosis | Stents

Korea, Republic of
Rambam Health Care Campus
Hadassah Medical Organization; Rabin Medical Center; The Chaim Sheba Medical...

Suspended

PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections (SPICE-M)

Bacteremia | Enterobacteriaceae Infections | Beta Lactam Resistant Bacterial Infection

Israel
University of Santiago de Compostela

Completed

Gingival Irritation Due to Bleaching Tray Design in an At-home Bleaching Treatment

Gingival Inflammation

Spain
University at Buffalo
AstraZeneca

Terminated

GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes (1981)

Kidney Diseases | Type2 Diabetes

United States
University of Colorado, Denver

Completed

Improving Insulin Resistance and Energy Metabolism Through Sleep Extension in Adolescents (REM)

Diabetes Mellitus, Type 2 | Sleep

United States
University of Arizona
National Cancer Institute (NCI); University of California, Los Angeles

Active, not recruiting

An Extended Follow-Up Study of the HPV Vaccine Delayed Booster Trial

HPV-associated Cancer

United States
Peking Union Medical College Hospital

Completed

Initial Volume Status in Patients With Acute Brain Injury is Associated With Neurological Prognosis

Acute Brain Injury | Paroxysmal Sympathetic Hyperactivity | Volume Status | Right Heart Function | Right Cardiogenic Pulmonary Edema | Glasgow Outcome Scale Extended

China
Janssen Korea, Ltd., Korea

Completed

A Study of the Newly Formulated Tylenol Tablet (Acetaminophen) to the Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants

Healthy

Korea, Republic of
Emory University
Centers for Disease Control and Prevention

Completed

Sentinel Cohort REACT

Multi-Drug Resistant Organism

United States
Indivior Inc.

Completed

Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations

Opioid Use Disorder

United States
Xiangya Hospital of Central South University

Completed

Clinical Outcomes and Decision-making Choice of Skull Base Approaches for Petroclival Meningiomas

Skull Base Meningioma

China
Second Affiliated Hospital of Soochow University

Active, not recruiting

A Clinical Study of Dihydroergotine Mesylate Extended-release Tablets for the Treatment of Drooling in Parkinson's Disease.

Salivation in Parkinson's Disease

China
Reata, a wholly owned subsidiary of Biogen

Terminated

An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) (EAGLE)

Chronic Kidney Diseases | Autosomal Dominant Polycystic Kidney | Alport Syndrome

United States, France, Australia, Japan, Spain, Puerto Rico
Clínica Rementería
Alcon Research

Completed

Tolerance to Residual Astigmatism in Eyes With Vivity®

Lenses, Intraocular

Spain
Johns Hopkins University

Terminated

Safety and Efficacy of Dexamethasone Ophthalmic Insert (Dextenza®) in the Management of Clinically Significant Dry Eye

Dry Eye

United States
Joslin Diabetes Center

Enrolling by invitation

Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study

Type 1 Diabetes | Monogenic Diabetes

United States
Corcym S.r.l

Terminated

Safety and Effectiveness Study of Perceval S Valve for Extended CE Mark (CAVALIER)

Aortic Valve Replacement

Belgium, Germany, Netherlands, France, Austria, Poland, Switzerland, United Kingdom
Campbell Clinic

Active, not recruiting

Extended Postoperative Oral Tranexamic Acid in Knee Replacement

Pain, Postoperative | Knee Osteoarthritis | Blood Loss

United States
Il-Yang Pharm. Co., Ltd.

Active, not recruiting

Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)

Chronic Myeloid Leukemia, Chronic Phase

China
Brigham and Women's Hospital

Active, not recruiting

Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism (HI-PRO)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese Subjects

Atopic Dermatitis

China
Sentara Norfolk General Hospital
Veloxis Pharmaceuticals

Completed

Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus (EVOKE-RT)

Transplant;Failure,Kidney

United States
Indivior Inc.

Active, not recruiting

Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users

Moderate to Severe Opioid-use Disorder

United States, Canada

Search clinical trials for: Extended Depth-of-Focus (EDOF)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations